cardiovascularhealth

Chronic illnesses can be classified under multiple umbrellas. But allergies are only official classified as an immune disorder. Should allergies be classified as a blood disorder as the histamine response occurs in the blood stream? Histamine is the chemical that is found in mast cells. When they leave the mast cells,histamines boost blood flow in the area of your body the allergen affected which can lead to certain symptoms depending on the part of the body where the histamine release occurs. For some it can lead to significant heart palpitations and anaphylactic shock, which can impact the circulatory system. In this episode Nurse Janara Iman-Thomas is going to talk about how pollens and foods get into the blood stream to cause allergies. She will share her passion for helping patients diagnose these allergies and prevent them from overburdening the immune system and reduce the inflammatory response in our bodies. ⦁    What are allergies. a histamine response in your blood.     - Once in blood stream – body knows what belongs there...     - Things that shouldn’t belong there... it has an immune response     - Body creates an antibody against those things....     - Sends out a little army of histamines and says attack.     - If it’s the first time... then your immune system handles ok.     - Then the next time it sees it – it is going to attack bigger.     - Building up a response to the point where you start having symptoms.     - It means your immune system is functioning, but overload.     - That’s where severe allergies happen. ⦁    How can allergies impact your cardiovascular system. Heart palpitations, high blood pressure, lack of oxygen in the blood ⦁    What are the different types of allergies - inhalants vs foods     - let's talk about how they each get into the bloodstream ⦁    How do allergies occur? how do they evolve over time.     - many want to know in detail how they go from a tree and mold or plant to food you eat ⦁    Advances in diagnosis ⦁    Advances in treatments

Cardiovascular diseases and allergic diseases occur commonly in developed countries. They lead to serious health complications and significantly impair the quality of life. Both types of diseases are characterized by excessive inflammatory processes. Recent studies suggest a link between allergy and an increased risk of cardiovascular disease, resulting from over activity of the immune system in allergic diseases and increased synthesis of pro-inflammatory mediators, which has been well documented in the pathogenesis of atherosclerosis.Data from the National Health Interview Survey demonstrated adults with a history of allergic disorders have an increased risk of high blood pressure and coronary heart disease, with the highest risk seen in Black male adults. The study is being presented at ACC Asia 2022 Together with the Korean Society of Cardiology Spring Conference on April 15-16, 2022."For patients with allergic disorders, routine evaluation of blood pressure and routine examination for coronary heart disease should be given by clinicians to ensure early treatments are given to those with hypertension or coronary heart disease," said Yang Guo, PhD, Department of Dermatology at the Institute of Dermatology at Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, and the study's lead author.

See omnystudio.com/listener for privacy information.

Getting diagnosed with a constriction or blockage in the arteries that supply blood to your brain can be quite daunting, as Nancy from South Carolina can confirm. She discovered she had carotid artery disease,which put her in danger of having a stroke. The carotid arteries, one on each side of the neck, are crucial blood vessels that provide blood to the brain, neck, and face. About one-third of all stroke cases are associated with diseased carotids. This disease arises when fatty residues, known as plaque, accumulate in these arteries. Alarmingly, in its initial stages, this disease often goes unnoticed due to a lack of symptoms. It only becomes noticeable when it becomes severe enough to deprive the brain of oxygen, resulting in a stroke or a transient ischemic attack (TIA). Lucky for Nancy, she discovered her condition early as she was under close observation following a heart attack. During a routine medical examination, a Physician Assistant detected a bruit, a turbulent flow in her neck arteries, using a stethoscope. In today's episode, Nancy shares her journey from diagnosis to receiving advanced treatment. Also joining us is the globally recognized Interventional Cardiologist Dr. Ehrin Armstrong, who discusses treatment guidelines and ongoing debates that could alter how and when doctors can offer more than just medication to enhance blood flow and avoid severe complications.

See omnystudio.com/listener for privacy information.

Deidre Arms, a medical professional specializing in women's health, was an energetic 46-year-old who cycled up to 32 miles a day. Despite her family's medical history, she believed her medical knowledge,passion for nutritious diet and supplements, and commitment to exercise were adequate in reducing her chances of suffering a stroke or heart attack. However, her cycling endurance suddenly plummeted, leaving her feeling easily worn out and short of breath. Medical professionals dismissed her symptoms as possibly adult-onset asthma.Two years later she suffered a heart attack. It was then that she encountered Dr. John Phillips, an Interventional Cardiologist and co-host of The Heart of Innovation. He guided her onto a path that not only saved her life but also led her to find her true life's calling: to educate, treat, and inspire others to enhance their cardiac health. Deidre shares her astonishing two-year struggle to make her doctors understand her situation and how she used this ordeal as a catalyst to prevent similar experiences for others

See omnystudio.com/listener for privacy information.

ಸೌತೆಕಾಯಿಗಳು ರಿಫ್ರೆಶ್ ಮತ್ತು ಆರೋಗ್ಯಕರ ತರಕಾರಿಯಾಗಿದ್ದು ಅದು ನಿಮಗೆ ಉತ್ತಮ ಆರೋಗ್ಯವನ್ನು ಕಾಪಾಡಿಕೊಳ್ಳಲು ಸಹಾಯ ಮಾಡುತ್ತದೆ. ದೇಹದಲ್ಲಿನ ವಿವಿಧ ಜೀವರಾಸಾಯನಿಕ ಕ್ರಿಯೆಗಳಲ್ಲಿ ತೊಡಗಿರುವ ಮೆಗ್ನೀಸಿಯಮ್ ಸೇರಿದಂತೆ ಪೋಷಕಾಂಶಗಳ ಶ್ರೇಣಿಯನ್ನು ಅವು ಒದಗಿಸುತ್ತವೆ. ಸೌತೆಕಾಯಿಗಳು ಈ ಅಗತ್ಯ ಖನಿಜದ ಅತ್ಯಂತ ಸ್ಪಷ್ಟವಾದ ಮೂಲವಾಗಿರದಿದ್ದರೂ, ಅವುಗಳು ವ್ಯತ್ಯಾಸವನ್ನು ಮಾಡಲು ಸಾಕಷ್ಟು ಹೊಂದಿರುತ್ತವೆ.

ಇಲ್ಲಿ ನಾವು ವಿವರಿಸುವ ಮಾಹಿತಿ ಕೇವಲ ಶೈಕ್ಷಣಿಕ ಉದ್ದೇಶಕ್ಕಾಗಿ ಮಾತ್ರ. ಹಾಗು ನಾವು ವಿವರಿಸುವ ಮಾಹಿತಿಯನ್ನು ಯಾರಾದರು ಅನುಸರಿಸುವ ಮೊದಲು ಪರಿಣಿತ ತಘ್ನರನ್ನು ಅಥವಾ ಪರಿಣಿತ ವೈದ್ಯರನ್ನು ಬೇಟಿ ನೀಡಿ.  ಹಾಗೂ ನಾವು ಚರ್ಚಿಸುವ ಅಥವಾ ವಿವರಿಸುವ ಮಾಹಿತಿಯಿಂದ ಆಗುವ ಅನಾನುಕೂಲಗಳಿಗೆ "ಆರೋಗ್ಯ ಕನ್ನಡ ಪಾಡ್ಕಾಸ್ಟ್ ಆಗಲೀ, "ಆರೋಗ್ಯ ಕನ್ನಡ"  ಪಾಡ್ಕಾಸ್ಟ್ ನ ಮಾಲೀಕರಾಗಲಿ ಜವಾಬ್ದಾರರಲ್ಲ .

Serial Entrepreneur Jeff Stevens is not a doctor. He’s never worked in medicine in any capacity. But he is making the changes we all want to see in medicine as a computer scientist. He cut his teeth on healthcare innovation, combining what he learned about the physics of a microphone when he worked as a music engineer intern starting in college, with data analytics he practiced as a risk mitigatory and technology futurist on Wall Street. Listen to how Jeff’s life unfolds from a boy on a paper route, to learning computer programming languages, to capitalizing on those manipulating the stock markets, to music engineer, to technology futurist and evangelist, to developing a diagnostic tool for expecting Moms that caught the attention of NASA, to ultimately creating what could bridge the gap in healthcare, putting potentially life-saving medical grade diagnostics in your hands that can be remotely monitored by your healthcare team. Hosts Kym McNicholas and Dr. John Phillips get inside the heart and the mind of this self-proclaimed ‘dreamer.’

See omnystudio.com/listener for privacy information.

In an introduction to Fatty Liver in Australia, Louise Campbell is joined by Tony Rahman, Director of Gastroenterology & Hepatology at The Prince Charles Hospital in Brisbane and Adjunct Professor in the College of Medicine and Dentistry at James Cook University.

Louise starts this conversation with an anecdote from her experiences in Australia providing virtual clinics to those living 6 to 10 hours drive away from their nearest consultation. She follows with a question to Tony on whether GPs want to buy into NAFLD and NASH in the same way that they responded to successful Hepatitis C programs. Tony replies yes, but alludes to some challenges in doing so. He notes the influence of how a problem and solution are presented has on the uptake of interest and whether the benefits posed are considered worthwhile. He explains that GPs in Australia are paid per patient and time away for education can be perceived as a loss of income. He suggests that rather than solely “bombarding GPs with education,” change will more readily be adopted if there is a robust plan in place. Conducting various environmental tests - even as simple as a GP focus group - considerably improves uptake of a newly introduced initiative. He continues on to describe a traffic light system adopted by the Prince Charles Hospital that utilizes FibroScan to assess the likelihood of a patient to develop liver disease in a given time. Louise comments on the importance of seeking constant refinement in establishing such systems.

Discussion shifts to the topic of guidelines and use of FIB-4 in the primary care setting. Louise asks whether use of FIB-4 is a part of any Australian protocol and, if not, is there any traction for its positioning as a readily available tool for risk stratification. Tony maintains it is making headway along with calculating an AST to Platelet Ratio Index (APRI), a popular measurement in the efforts of moving patients along Hepatitis C treatment. Today, he is wary that GPs who are seeing a large number of patients may not have the time or prioritize making calculations. At this point, Louise points to the idea of joint referrals in light of emerging recommendations from the cardiology community on risk assessment of NAFLD. She notes the combined uptake of FIB-4 and FibroScan as something potentially valuable to an initiative such as Heart of Australia. Tony points out that establishing convincing clarity around the links between Fatty Liver disease and cardiovascular outcomes is conducive to the protocol-led Australian doctors. At the end of the session, Tony illustrates potential challenges in Australia not having a FibroScan medicare billing code and comments on factors which affect accessibility.